P Pianosi1, J Leblanc, A Almudevar. 1. Department of Pediatrics, Dalhousie University, Halifax, Canada B3J 3G9. ppianosi@dal.ca
Abstract
BACKGROUND: Single measurements of peak oxygen uptake (VO2) have been shown to predict mortality in patients with cystic fibrosis (CF) although no longitudinal study of serial measurements has been reported in children. A study was undertaken to determine whether the initial, final, or the rate of fall of forced expiratory volume in 1 second (FEV1) or peak VO2 was a better predictor of mortality. METHODS: Twenty eight children aged 8-17 years with CF performed annual pulmonary function and maximal exercise tests over a 5 year period to determine FEV1 and peak VO2, magnitude of their change over time, and survival over the subsequent 7-8 years. Analysis was done using Kaplan-Meier curves and Cox proportional hazard model. RESULTS: Peak VO2 fell during the observation period in 70% of the patients, with a mean annual decline of 2.1 ml/min/kg. Initial peak VO2 was not predictive of mortality but rate of decline and final peak VO2 of the series were significant predictors. Patients with peak VO2 less than 32 ml/min/kg exhibited a dramatic increase in mortality, in contrast to those whose peak VO2 exceeded 45 ml/min/kg, none of whom died. The first, last, and rate of decline in FEV1 over time were all significant predictors of mortality. CONCLUSIONS: Higher peak VO2 is a marker for longer survival in CF patients.
BACKGROUND: Single measurements of peak oxygen uptake (VO2) have been shown to predict mortality in patients with cystic fibrosis (CF) although no longitudinal study of serial measurements has been reported in children. A study was undertaken to determine whether the initial, final, or the rate of fall of forced expiratory volume in 1 second (FEV1) or peak VO2 was a better predictor of mortality. METHODS: Twenty eight children aged 8-17 years with CF performed annual pulmonary function and maximal exercise tests over a 5 year period to determine FEV1 and peak VO2, magnitude of their change over time, and survival over the subsequent 7-8 years. Analysis was done using Kaplan-Meier curves and Cox proportional hazard model. RESULTS: Peak VO2 fell during the observation period in 70% of the patients, with a mean annual decline of 2.1 ml/min/kg. Initial peak VO2 was not predictive of mortality but rate of decline and final peak VO2 of the series were significant predictors. Patients with peak VO2 less than 32 ml/min/kg exhibited a dramatic increase in mortality, in contrast to those whose peak VO2 exceeded 45 ml/min/kg, none of whom died. The first, last, and rate of decline in FEV1 over time were all significant predictors of mortality. CONCLUSIONS: Higher peak VO2 is a marker for longer survival in CF patients.
Authors: R Sharma; V G Florea; A P Bolger; W Doehner; N D Florea; A J Coats; M E Hodson; S D Anker; M Y Henein Journal: Thorax Date: 2001-10 Impact factor: 9.139
Authors: Hiran C Selvadurai; Karen O McKay; Cameron J Blimkie; Peter J Cooper; Craig M Mellis; Peter P Van Asperen Journal: Am J Respir Crit Care Med Date: 2002-03-15 Impact factor: 21.405
Authors: Mark P Rogan; Clifford C Taggart; Catherine M Greene; Philip G Murphy; Shane J O'Neill; Noel G McElvaney Journal: J Infect Dis Date: 2004-08-26 Impact factor: 5.226
Authors: Gabriel Somarriba; Gabriela Lopez-Mitnik; David A Ludwig; Daniela Neri; Natasha Schaefer; Steven E Lipshultz; Gwendolyn B Scott; Tracie L Miller Journal: AIDS Res Hum Retroviruses Date: 2012-07-31 Impact factor: 2.205
Authors: Matthew A Tucker; Breana Berry; Nichole Seigler; Gareth W Davison; John C Quindry; Dabney Eidson; Kathleen T McKie; Ryan A Harris Journal: J Cyst Fibros Date: 2017-10-12 Impact factor: 5.482
Authors: Courtney M Wheatley; Sarah E Baker; Mary A Morgan; Marina G Martinez; Bo Liu; Steven M Rowe; Wayne J Morgan; Eric C Wong; Stephen R Karpen; Eric M Snyder Journal: Respir Med Date: 2015-05-23 Impact factor: 3.415
Authors: Matthew A Tucker; Nichole Lee; Paula Rodriguez-Miguelez; Jacob Looney; Reva H Crandall; Caralee Forseen; Kathleen T McKie; Ryan A Harris Journal: Eur J Appl Physiol Date: 2018-10-24 Impact factor: 3.078